Impact of Left Ventricular Hypertrophy Late After Aortic Valve Replacement for Aortic Stenosis on Cardiovascular Morbidity and Mortality.
From: Cardiology, University Hospital Inselspital, Swiss Cardiovascular Center Bern, Bern, Switzerland. renate.zybach@bluewin.ch
International journal of cardiology
- Publish Date: Apr 2006
- ISSN: 0167-5273
- Volume: 109
- Issue: 1
- Pages: 41-7
- Medium: Print
- Language: English
- Citation (JAMA): Zybach-Benz Renate E, Aeschbacher Beat C, Schwerzmann Markus, et al. Impact of Left Ventricular Hypertrophy Late After Aortic Valve Replacement for Aortic Stenosis on Cardiovascular Morbidity and Mortality.. Int. J. Cardiol. Apr 2006;109:41-7
Abstract
AIMS: The goal of this study was to assess the prevalence of left ventricular (LV) hypertrophy in patients with aortic stenosis late (>6 months) after aortic valve replacement and its impact on cardiac-related morbidity and mortality. METHODS AND RESULTS: In a single tertiary centre, echocardiographic data of LV muscle mass were collected. Detailed information of medical history and angiographic data were gathered. Ninety-nine of 213 patients (46%) had LV hypertrophy late (mean 5.8 +/- 5.4 years) after aortic valve replacement. LV hypertrophy was associated with impaired exercise capacity, higher New York Heart Association dyspnoea class, a tendency for more frequent chest pain expressed as higher Canadian Cardiovascular Society class, and more rehospitalizations. 24% of patients with normal LV mass vs. 39% of patients with LV hypertrophy reported cardiac-related morbidity (p = 0.04). In a multivariate logistic regression model, LV hypertrophy was an independent predictor of cardiac-related morbidity (odds ratio 2.31, 95% CI 1.08 to 5.41), after correction for gender, baseline ejection fraction, and coronary artery disease and its risk factors. Thirty seven deaths occurred during a total of 1959 patient years of follow-up (mean follow-up 9.6 years). Age at aortic valve replacement (hazard ratio 1.85, 95% CI 1.39 to 2.47, for every 5 years increase in age), coexisting coronary artery disease at the time of surgery (hazard ratio 3.36, 95% CI 1.31 to 8.62), and smoking (hazard ratio 4.82, 95% CI 1.72 to 13.45) were independent predictors of overall mortality late after surgery, but not LV hypertrophy. CONCLUSIONS: In patients with aortic valve replacement for isolated aortic stenosis, LV hypertrophy late after surgery is associated with increased morbidity.
Mesh Headings (Keywords): Adult, Aged, Aortic Valve Stenosis, Female, Heart Diseases, Heart Valve Prosthesis Implantation, Hospitalization, Humans, Hypertrophy, Left Ventricular, Logistic Models, Male, Middle Aged, Morbidity, Multivariate Analysis, Postoperative Complications, Prevalence, Prognosis, Retrospective Studies, Risk Factors, Survival Analysis, Time Factors
Check for Full Text / PubMed Unique Identifier (PMID): 15996776
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.